Registration SM27956 · in-house
AstraZeneca Canada Inc.
Who
- Client
- AstraZeneca Canada Inc.
- Registrant
- Gaby Bourbara
- Type
- in-house
- Status
- active
- Dates
- Approved 3 April 2019; 1 April 2019 to 31 December 2026
Subject matter
- Economic Development
Source: City of Toronto Lobbyist Registry (open data). Dataset page.
Particulars
The impact of Federal drug pricing regulation changes on jobs, investment and research in the biopharmaceutical sector in the Greater Toronto Region.
Automated summary of the registration text
registered, communicating about the impact of Federal drug pricing regulation changes on jobs, investment and research in the biopharmaceutical sector in the Greater Toronto Region
Generated from the registration text only. Read the particulars for the registrant's own words.
Lobbyists
Organisations named
Communications
No communications recorded.
"Member's office" is the member of council whose office was contacted (the member or their staff), resolved from the office holder name and office recorded in the registry.
Linked agenda items
No published links to agenda items.
Linked development applications
No published links to development or Committee of Adjustment applications.